非酒精性脂肪肝患者肝脏固醇调节元件结合蛋白1c的表达及意义

摘要

Objective To investigate the hepatic expression of sterol regulatory element binding protein (SREBP)-1c in patients with non-alcoholic fatty liver disease (NAFLD) and its significance.Methods Twenty patients with NAFLD were included,and 20 age/sex matched asymptomatic HBV carriers (ASC) without steatosis evidenced by liver biopsy were used as control in the same time scale.Hepatic SREBP1c was detected using SP method of immunohistochemistry.An automatic biochemical analyzer (Hitachi 7060) was used to measure serum levels of lipids (TG,CHO),fasting blood glucose (FBG) and liver enzymes (AST,A LT,and GGT),and electrochemiluminescence was used to determine fasting insulin (FINS).Results Compared with the control group,NAFLD patients showed diffusely hepatic steatosis and a significantly higher expression of hepatic SREBP1c (P ＜ 0.05).Consistently,serum levels of ALT,AST,TG,CHO,FSG and FINS all increased than those of control group (P ＜ 0.05).Conclusions Hepatic expression of SREBP1c increased significantly in patients with NAFLD,and this over expression may be involve in fatty degeneration of the livers in human.%目的 观察非酒精性脂肪性肝病(NAFLD)患者肝组织固醇调节元件结合蛋白(SREBP1c)的表达变化,探讨其在NAFLD病理变化形成中的作用.方法 研究对象为NAFLD患者20例,20例年龄性别匹配的同期住院行肝活检无活动肝病组织学证据且肝脂肪变＜5％的慢性HBV携带者(ASC)设为对照组.免疫组织化学染色检测两组患者肝组织SREBP1c的表达,并比较血脂(TG、CHO)、空腹血糖(FBG)、空腹胰岛素(FINS)和血清肝脏酶谱(AST、ALT、GGT)等的组间差异.结果 与对照组患者比较,NAFLD组肝组织呈不同程度的弥漫性肝细胞脂肪变性,肝组织SREBP1c表达明显升高(P＜0.05),与此一致,血清ALT、AST、TG、CHO、FBG、FINS水平升高(P均＜0.05).结论 NAFLD患者肝组织SREBP1 c表达增高,在人NAFLD脂肪变形成过程中起重要作用.